We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$56.9M
Cap. Flow
+$55.4M
Cap. Flow %
18.67%
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$25.2M
2
INVH icon
Invitation Homes
INVH
+$6.9M
3
AMH icon
American Homes 4 Rent
AMH
+$3.4M
4
LAZR
Luminar Technologies
LAZR
+$1.51M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$1.34M

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$978K
2
OMCL icon
Omnicell
OMCL
+$641K
3
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$568K
4
RAVN
Raven Industries Inc
RAVN
+$373K
5
NNDM
Nano Dimension
NNDM
+$287K

Sector Composition

Rank Sector Weight
1 Real Estate 18.29%
2 Healthcare 13.15%
3 Technology 2%
4 Industrials 1.37%
5 Consumer Discretionary 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
76
Cytokinetics
CYTK
$10.9B
$291K 0.1%
12,500
– –
JNK icon
77
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.29B
$287K 0.1%
2,634
+253
+11% +$27.5K
SHYG icon
78
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$287K 0.1%
6,268
+587
+10% +$26.7K
GHYG icon
79
iShares US & Intl High Yield Corp Bond ETF
GHYG
$185M
$284K 0.1%
5,658
+520
+10% +$26.2K
ADAP
80
DELISTED
Adaptimmune Therapeutics
ADAP
$271K 0.09%
51,000
+7,000
+16% +$40.1K
TBIO
81
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$264K 0.09%
+16,000
New +$365K
VLO icon
82
Valero Energy
VLO
$92.9B
$263K 0.09%
3,674
-66
-2% -$4.49K
RETA
83
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$249K 0.08%
+2,500
New +$292K
ITCI
84
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$238K 0.08%
7,000
-1,000
-13% -$34.7K
IDYA icon
85
IDEAYA Biosciences
IDYA
$3.49B
$235K 0.08%
10,000
-2,500
-20% -$48.3K
VNQ icon
86
Vanguard Real Estate ETF
VNQ
$39.4B
$223K 0.08%
2,432
+146
+6% +$12.8K
CVS icon
87
CVS Health
CVS
$137B
$222K 0.07%
2,948
-79
-3% -$5.75K
PFF icon
88
iShares Preferred and Income Securities ETF
PFF
$13.3B
$220K 0.07%
5,718
+629
+12% +$23.9K
VNQI icon
89
Vanguard Global ex-US Real Estate ETF
VNQI
$3.48B
$218K 0.07%
3,910
+281
+8% +$15.4K
ZNTL icon
90
Zentalis Pharmaceuticals
ZNTL
$371M
$217K 0.07%
+5,000
New +$215K
IPFF
91
DELISTED
iShares International Preferred Stock ETF
IPFF
$217K 0.07%
13,142
+366
+3% +$5.95K
COLL icon
92
Collegium Pharmaceutical
COLL
$1.15B
$213K 0.07%
9,000
– –
LHDX
93
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$206K 0.07%
+17,000
New +$337K
NBIX icon
94
Neurocrine Biosciences
NBIX
$17.4B
$195K 0.07%
2,000
-800
-29% -$83.9K
PBYI icon
95
Puma Biotechnology
PBYI
$423M
$194K 0.07%
20,000
+10,500
+111% +$117K
ARNA
96
DELISTED
Arena Pharmaceuticals Inc
ARNA
$191K 0.06%
2,750
– –
ZYME icon
97
Zymeworks
ZYME
$1.77B
$189K 0.06%
+6,000
New +$244K
RVNC
98
DELISTED
Revance Therapeutics, Inc.
RVNC
$182K 0.06%
6,500
+4,000
+160% +$111K
XLI icon
99
State Street Industrial Select Sector SPDR ETF
XLI
$33.2B
$176K 0.06%
1,787
+134
+8% +$12.3K
XLP icon
100
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
$175K 0.06%
2,557
+383
+18% +$25.2K
2 3
4
5 6

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.

  • AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
  • AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
  • AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
  • AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
  • AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.